News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Repros Therapeutics Inc. (RPRX) to Present Androxal® and Proellex® Clinical Updates at the Lazard Capital Markets 9th Annual Healthcare Conference


11/5/2012 9:14:33 AM

THE WOODLANDS, Texas, Nov. 5, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX)today announced the Company will present clinical updates for both its Androxal® and Proellex® programs Wednesday, November 14, 2012, at 8 am Eastern time. The Company is not webcasting the presentation but will have the slides available on its website, www.reprosrx.com, the morning of the presentation.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES